# A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index

> **NCT02276898** · PHASE2 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 24 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Hypertonic Saline 7%
- **DRUG:** Isotonic Saline 0.9% (Placebo)

## Key facts

- **NCT ID:** NCT02276898
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2015-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02276898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02276898, "A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance Index". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02276898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*